Kiora Pharmaceuticals (KPRX) P/E (2015 - 2026)
Kiora Pharmaceuticals (KPRX) P/E from Jul 31, 2015 to Jun 3, 2026. The TTM Kiora Pharmaceuticals (KPRX) P/E is -0.91. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Kiora Pharmaceuticals (KPRX)
| Year | P/E | Change |
|---|---|---|
| 2026 | -0.91 | +41.74% |
| 2025 | -0.64 | -125.60% |
| 2024 | 2.50 | -1770.63% |
| 2023 | -0.15 | -87.08% |
| 2022 | -1.16 | -94.32% |
| 2021 | -20.39 | -54.12% |
| 2020 | -44.44 | -37.59% |
| 2019 | -71.21 | +237.70% |
| 2018 | -21.09 | +40.30% |
| 2017 | -15.03 | -12.52% |
| 2016 | -17.18 | -49.52% |
| 2015 | -34.03 | N/A |
Comparison Kiora Pharmaceuticals (KPRX) P/E with competitors
Kiora Pharmaceuticals (KPRX) P/E is -0.91.